Hypogammaglobulinemia due to CAR T-cell therapy

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

(2015) David L. Porter et al.   Science Translational Medicine

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

(2014) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hypogammaglobulinaemia after rituximab treatment--incidence and outcomes

(2014) M. Makatsori et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

The Basic Principles of Chimeric Antigen Receptor Design

(2013) Michel Sadelain et al.   Cancer Discovery

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

(2011) J. N. Kochenderfer et al.   BLOOD

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

(2010) J. N. Kochenderfer et al.   BLOOD

Immunoglobulin Replacement Therapy in Children

(2008) Maria Garcia-Lloret et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA